1 results match your criteria: "From the *Hung Vuong Hospital[Affiliation]"
The safety and immunogenicity of two hepatitis B vaccine formulations (thiomersal-free and thiomersal-containing) in healthy vietnamese infants: a phase III, prospective, single-blinded, randomized, controlled trial.
Pediatr Infect Dis J
January 2015
From the *Hung Vuong Hospital, Ho Chi Minh City, Vietnam; †Crucell Switzerland AG, Bern, Switzerland; and ‡Crucell Holland BV, CN Leiden, The Netherlands.
Article Synopsis
- The study aimed to assess the safety and effectiveness of two Hepavax-Gene formulations (thimerosal-free and thimerosal-containing) in healthy newborns in Vietnam.
- Both types of vaccines were administered following a standard schedule, and blood samples were collected afterward to evaluate immune responses and track any adverse events reported by caregivers.
- Results showed high seroprotection rates for both formulations, no significant differences in reported side effects, and the thiomersal-free option was linked to fewer local adverse reactions, confirming its safety and equal immunogenicity to the thimerosal-containing version.